Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy

Stopped early

Conditions studied: Heart Failure, Cardiogenic Shock

In brief

The purpose of this study is to gather information on patients who have heart failure and are eligible for one of the following two procedures: 1) mechanical support, i.e. ventricular assist device (VAD) or 2) heart transplant. the study seeks to determine which patient populations benefit from heart transplant or ventricular assist device. This will allow to offer the state-of-the-art care to the patients in heart failure.

Key facts

Study ID

NCT02790242

Run by

Columbia University

People needed

1089

Starts

2013-11-01

Expected to finish

2020-02-11

Last updated by the study team

2023-04-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adult patients who receive any MCSD including Veno-Arterial Extracorporeal Membrane Oxygenation (VA ECMO), surgical VAD, and percutaneous VAD, used to treat CS on or after 9/30/10. Intraaortic balloon pumping (IABP) is not considered an MCSD in this Registry.
• Adult patients who have signed informed consent. For patients who are too ill to give informed consent the health care proxy of the patient or next of kin will be approached for the informed consent.

You may not qualify if…

• patients younger than 18 years of age.

Where it is running

• University of Colarodo — Aurora, Colorado, United States
• Minneapolis Heart Institute — Minneapolis, Minnesota, United States
• Washington University — St Louis, Missouri, United States
• Newark Beth Israel Medical center — Newark, New Jersey, United States
• Columbia University Irving Medical Center — New York, New York, United States
• Westchester Medical Center — Valhalla, New York, United States
• Duke University Medical Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.